Literature DB >> 2452128

Selective induction of mononuclear phagocytes to produce neopterin by interferons.

G Bitterlich1, G Szabó, E R Werner, C Larcher, D Fuchs, A Hausen, G Reibnegger, T F Schulz, J Troppmair, H Wachter.   

Abstract

Interferon-gamma (IFN-gamma) has been shown to be a potent inducer of neopterin secretion by human peripheral blood monocytes/macrophages (1). In this paper, it is shown that other known stimuli of monocytes (e.g., to secrete proteases or to migrate) such as zymosan-activated human serum, lipopolysaccharide, human C3/iC3 and zymosan coated with complement were unable to trigger monocytes/macrophages to release neopterin. Monocytes/macrophages could be stimulated solely by IFN-gamma (25 U/ml) and IFN-alpha at very high concentrations (10,000 U/ml). In the case of human peripheral blood mononuclear cells (PBMNC), basically the same pattern was observed. If however, in the buffer controls PBMNC showed some neopterin release, all stimuli triggered an increase of neopterin secretion: 10,000 U/ml IFN-alpha induced the same amount of secreted neopterin as did 25 U/ml of IFN-gamma. Both caused higher levels of neopterin secretion than ZAS, LPS and C3/iC3. Amongst the supernatants from PBMNC, only those which were obtained from cells activated with IFN-gamma or -alpha stimulated monocytes/macrophages to produce neopterin. Supernatants from lymphocytes activated with zymosan, lipopolysaccharide and interferon did not contain neopterin, nor did the latter induce monocytes/macrophages to generate and secrete neopterin. Antibodies against IFN-gamma inhibited the triggering effect of the supernatants except when generated by IFN-alpha at 10,000 U/ml. These results demonstrate that both interferons, IFN-gamma and IFN-alpha, the latter only at a 400-fold higher concentration, can trigger monocytes/macrophages directly to secrete neopterin. ZAS, LPS and C3/iC3 are weakly effective only on a mixture of lymphocytes and monocytes/macrophages, provided this cell mixture shows already a basic spontaneous neopterin release.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452128     DOI: 10.1016/S0171-2985(88)80055-X

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  5 in total

1.  Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin.

Authors:  J Chiang; C A Gloff; C N Yoshizawa; G J Williams
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

2.  Enhanced interferon-gamma by CD8+ CD28- lymphocytes from HIV+ patients.

Authors:  E H Eylar; C Lefranc; I Báez; S L Colón-Martinez; Y Yamamura; N Rodriguez; N Yano; T B Breithaupt
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

3.  Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.

Authors:  B Hofmann; H Bass; P Nishanian; M Faisal; R A Figlin; G P Sarna; J L Fahey
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

4.  Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.

Authors:  G Hahn; B Stuhlmüller; N Hain; J R Kalden; K Pfizenmaier; G R Burmester
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

5.  Direct and indirect effects of human interferon alpha on renal cell carcinoma: a new in vitro assay system for evaluating cytokine-mediated antitumor effects.

Authors:  H Matsuyama; S Yoshihiro; Y Ohmoto; N Yamamoto; K Naito
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.